We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AGC Acquires CMC Biologics

News   Jan 12, 2017 | Original Story From CMC Biologics

 
AGC Acquires CMC Biologics
 
 
Advertisement
 

RELATED ARTICLES

COVID-19 Vaccine Prioritization and the Impact of Non-Pharmaceutical Interventions

News

To effectively reduce SARS-CoV-2 transmission and improve long-term health, tactical delivery of COVID-19 vaccines is essential. This was the conclusion of a recent study published in PLOS Computational Biology. A team of UK-based researchers found that prioritizing the distribution of the vaccine to at-risk groups, including the elderly and those with underlying health conditions, had the greatest impact in terms of minimizing the number of lives lost to the disease.

READ MORE

Real-World Data Suggests Two Doses of Pfizer Vaccine Provides Over 95% Protection

News

An observational study published in The Lancet has explored the real-world effectiveness of the Pfizer–BioNTech mRNA COVID-19 vaccine (BNT162b2) against a variety of outcomes.

READ MORE

Cannabis-Derived Drug Exhibits Pain-Halting Effects in Mice

News

A novel cannabidiol (CBD) analog known as KLS-13019 prevented the development of neuropathy and reversed pain sensitivity in a mouse model of chemotherapy-induced peripheral neuropathy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE